Vigil Neuroscience Stock Buy Hold or Sell Recommendation
| VIGL Stock | USD 2.30 0.10 4.55% |
Given the investment horizon of 90 days and complete risk avoidance on your part, our recommendation regarding Vigil Neuroscience is 'Strong Sell'. The recommendation algorithm takes into account all of Vigil Neuroscience's available fundamental, technical, and predictive indicators you will find on this site.
Check out Vigil Neuroscience Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Vigil Stock please use our How to buy in Vigil Stock guide. Note, we conduct extensive research on individual companies such as Vigil and provide practical buy, sell, or hold advice based on investors' constraints. Vigil Neuroscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
Vigil |
Execute Vigil Neuroscience Buy or Sell Advice
The Vigil recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Vigil Neuroscience. Macroaxis does not own or have any residual interests in Vigil Neuroscience or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Vigil Neuroscience's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Moderately volatile | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Above Average | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Vigil Neuroscience Trading Alerts and Improvement Suggestions
| Vigil Neuroscience generated a negative expected return over the last 90 days | |
| Vigil Neuroscience has high historical volatility and very poor performance | |
| Vigil Neuroscience has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (82.64 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Vigil Neuroscience currently holds about 148.91 M in cash with (70.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.27, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Vigil Neuroscience has a frail financial position based on the latest SEC disclosures | |
| Over 80.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from investing.com: Guggenheim maintains Buy on Vigil Neuroscience stock post-Alector trial |
Vigil Neuroscience current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Vigil analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Vigil analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Average Consensus Strong Buy
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Vigil Neuroscience Returns Distribution Density
The distribution of Vigil Neuroscience's historical returns is an attempt to chart the uncertainty of Vigil Neuroscience's future price movements. The chart of the probability distribution of Vigil Neuroscience daily returns describes the distribution of returns around its average expected value. We use Vigil Neuroscience price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Vigil Neuroscience returns is essential to provide solid investment advice for Vigil Neuroscience.
| Mean Return | -0.48 | Value At Risk | -7.22 | Potential Upside | 6.33 | Standard Deviation | 5.01 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Vigil Neuroscience historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Vigil Stock Institutional Investors
| Shares | Pivotal Bioventure Partners Investment Advisor Llc | 2024-06-30 | 560.6 K | Rock Springs Capital Management Lp | 2024-06-30 | 472 K | Orbimed Advisors, Llc | 2024-06-30 | 448.9 K | Blackrock Inc | 2024-06-30 | 405 K | Goldman Sachs Group Inc | 2024-06-30 | 401.1 K | Millennium Management Llc | 2024-06-30 | 334.8 K | Arrowmark Colorado Holdings, Llc (arrowmark Partners) | 2024-09-30 | 289.5 K | Abrdn Plc | 2024-09-30 | 235 K | Geode Capital Management, Llc | 2024-09-30 | 226.1 K | Northpond Ventures, Llc | 2024-09-30 | 4.2 M | Artal Group S A | 2024-06-30 | 1.8 M |
Vigil Neuroscience Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Vigil Neuroscience or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Vigil Neuroscience's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Vigil stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.55 | |
β | Beta against Dow Jones | 0.51 | |
σ | Overall volatility | 5.11 | |
Ir | Information ratio | -0.12 |
Vigil Neuroscience Volatility Alert
Vigil Neuroscience exhibits very low volatility with skewness of -2.1 and kurtosis of 11.2. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Vigil Neuroscience's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Vigil Neuroscience's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Vigil Neuroscience Fundamentals Vs Peers
Comparing Vigil Neuroscience's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Vigil Neuroscience's direct or indirect competition across all of the common fundamentals between Vigil Neuroscience and the related equities. This way, we can detect undervalued stocks with similar characteristics as Vigil Neuroscience or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Vigil Neuroscience's fundamental indicators could also be used in its relative valuation, which is a method of valuing Vigil Neuroscience by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Vigil Neuroscience to competition |
| Fundamentals | Vigil Neuroscience | Peer Average |
| Return On Equity | -0.7 | -0.31 |
| Return On Asset | -0.4 | -0.14 |
| Current Valuation | (4.07 M) | 16.62 B |
| Shares Outstanding | 40.88 M | 571.82 M |
| Shares Owned By Insiders | 21.27 % | 10.09 % |
| Shares Owned By Institutions | 80.15 % | 39.21 % |
| Number Of Shares Shorted | 736.69 K | 4.71 M |
| Price To Book | 1.06 X | 9.51 X |
| EBITDA | (88.47 M) | 3.9 B |
| Net Income | (82.64 M) | 570.98 M |
| Cash And Equivalents | 148.91 M | 2.7 B |
| Cash Per Share | 5.27 X | 5.01 X |
| Total Debt | 13.85 M | 5.32 B |
| Debt To Equity | 0 % | 48.70 % |
| Current Ratio | 21.35 X | 2.16 X |
| Book Value Per Share | 3.24 X | 1.93 K |
| Cash Flow From Operations | (70.36 M) | 971.22 M |
| Short Ratio | 5.31 X | 4.00 X |
| Earnings Per Share | (2.07) X | 3.12 X |
| Target Price | 15.88 | |
| Number Of Employees | 64 | 18.84 K |
| Beta | 1.93 | -0.15 |
| Market Capitalization | 94.02 M | 19.03 B |
| Total Asset | 140.86 M | 29.47 B |
| Retained Earnings | (222.77 M) | 9.33 B |
| Working Capital | 110.25 M | 1.48 B |
| Net Asset | 140.86 M |
Note: Disposition of 135000 shares by Ziolkowski Jennifer Lynn of Vigil Neuroscience at 11.87 subject to Rule 16b-3 [view details]
Vigil Neuroscience Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Vigil . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Vigil Neuroscience Buy or Sell Advice
When is the right time to buy or sell Vigil Neuroscience? Buying financial instruments such as Vigil Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Vigil Neuroscience in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Convertibles Funds Thematic Idea Now
Convertibles Funds
Funds or Etfs that invest in debt that is expected to be converted into a predetermined amount of the company equity at some future date. The Convertibles Funds theme has 15 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Convertibles Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Vigil Neuroscience Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Vigil Stock please use our How to buy in Vigil Stock guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vigil Neuroscience. If investors know Vigil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vigil Neuroscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.07) | Return On Assets (0.40) | Return On Equity (0.70) |
The market value of Vigil Neuroscience is measured differently than its book value, which is the value of Vigil that is recorded on the company's balance sheet. Investors also form their own opinion of Vigil Neuroscience's value that differs from its market value or its book value, called intrinsic value, which is Vigil Neuroscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vigil Neuroscience's market value can be influenced by many factors that don't directly affect Vigil Neuroscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vigil Neuroscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vigil Neuroscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vigil Neuroscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.